The business strategies of companies involved in chiral drug development were cast into doubt in October after Eli Lilly (Indianapolis, IL) decided not to pursue the development of R-fluoxetine ...

By exploiting the specific interactions between chiral nanomaterials and target molecules, researchers have developed chiral sensors and separation techniques for applications in drug discovery, ...

Scientists engaged in drug development research depend on analytical chemistry techniques that allow them to separate compounds in preparation for downstream workflows. However, traditional separation ...

Chiral conversion and peptidization dynamics in amino acids are critical areas of research in chemistry and biochemistry, particularly due to their implications in drug development and protein ...

Daniel Armstrong, the Robert A. Welch Distinguished Professor in Chemistry at The University of Texas at Arlington, will be ...

Promising UCF technology is illuminating new ways to examine molecules with precision, an advancement that can help enhance drug development and new therapies. The new technology, a plasmonic ...